Cytomegalovirus retinitis following intravitreal injection of triamcinolone: Report of two cases

50Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Context: Cytomegalovirus (CMV) retinitis usually affects severely immunosuppressed individuals. However, some exceptional and isolated cases of CMV retinitis have been described in immunocompetent patients. Methods: We report two cases of non-immunodeficient patients seen in our institution over a period of 6 months, who presented with CMV retinitis a few weeks after an intravitreal injection of triamcinolone acetonide. Results: Although the cellular and molecular mechanisms underlying the development of CMV in an immunocompetent patient's eye have not yet been precisely established, the well known immunosuppressive properties of corticosteroids suggest that triamcinolone probably plays a role in the endogenous reactivation of latent CMV. Conclusions: Our two patients received high doses of triamcinolone. Both had also pseudophakia, vitrectomy and a past medical history of type 2 diabetes mellitus. Such features, individually or combined, may be risk factors for local reactivation of CMV and should be considered prior to the administration of triamcinolone acetonide in ophthalmology. © 2007 The Authors Journal compilation © 2007 Acta Ophthalmol Scand.

Cite

CITATION STYLE

APA

Delyfer, M. N., Rougier, M. B., Hubschman, J. P., Aouizérate, F., & Korobelnik, J. F. (2007). Cytomegalovirus retinitis following intravitreal injection of triamcinolone: Report of two cases. Acta Ophthalmologica Scandinavica, 85(6), 681–683. https://doi.org/10.1111/j.1600-0420.2007.00915.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free